Shelcal CT Tablet – Calcium & Calcitriol for Bone Health
Shelcal CT Tablet is a nutritional supplement containing Calcium Carbonate and Calcitriol, formulated to support bone health, aid calcium absorption and maintain overall skeletal strength. This film-coated tablet helps prevent and manage calcium deficiency and supports the management of conditions such as osteoporosis and hypocalcemia.
Key Features
- Combines Calcium Carbonate with Calcitriol (active Vitamin D3) for better absorption
- Supports bone formation, density and overall skeletal strength
- Helps manage nutritional calcium deficiency and related conditions
- Convenient film-coated tablet suitable for daily supplementation
Active / Key Ingredients
Calcium Carbonate and Calcitriol.
Uses / Benefits
- Supports strong bones and teeth with regular use
- Aids in the management of osteoporosis and calcium deficiency
- Improves calcium absorption through the active Vitamin D3 metabolite Calcitriol
- Supports overall skeletal maintenance in adults at risk of nutritional gaps
How to Use
Take one tablet daily, or as directed by your physician, preferably with food. Swallow the tablet whole with a glass of water. Do not exceed the dose prescribed by your doctor.
Precautions
- Use only as prescribed by a Registered Medical Practitioner
- Not to be sold by retail without a valid prescription
- Inform your doctor if you have kidney disease or high blood calcium levels
- Keep out of reach of children
Side Effects
Shelcal CT is generally well tolerated when taken as prescribed. Mild constipation, nausea or an upset stomach may occur in some individuals – consult your doctor if symptoms persist.
Storage
Store in a cool, dry place below 25°C, away from direct sunlight and out of reach of children.
Legal Disclaimer
This product information is for general reference only and does not replace professional medical advice. Shelcal CT Tablet should be used strictly under medical supervision and as prescribed by a qualified physician.













Reviews
There are no reviews yet.